← Evidence map

ReviewCancers2026

Drug-Tolerant Persister Cells and Tumor Dormancy in NSCLC: A New Frontier in Overcoming Therapeutic Resistance.

Mumtu Lalla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41827714